Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 193

1.

Are Pathogenic Leptospira Species Agents of Community-Acquired Pneumonia? Case Reports of Leptospirosis Presenting as Pneumonia.

Gasem MH, Farida H, Ahmed A, Severin JA, Suryanto A, Isbandrio B, Verbrugh HA, Hartskeerl RA, van den Broek PJ.

J Clin Microbiol. 2016 Jan;54(1):197-9. doi: 10.1128/JCM.02093-15. Epub 2015 Oct 28.

2.

Viruses and Gram-negative bacilli dominate the etiology of community-acquired pneumonia in Indonesia, a cohort study.

Farida H, Gasem MH, Suryanto A, Keuter M, Zulkarnain N, Satoto B, van der Eijk AA, Djokomoeljanto R, Wahyono H, Verbrugh HA, Severin JA, van den Broek PJ.

Int J Infect Dis. 2015 Sep;38:101-7. doi: 10.1016/j.ijid.2015.07.023. Epub 2015 Aug 6.

3.

Development of quality indicators to evaluate antibiotic treatment of patients with community-acquired pneumonia in Indonesia.

Farida H, Rondags A, Gasem MH, Leong K, Adityana A, van den Broek PJ, Keuter M, Natsch S.

Trop Med Int Health. 2015 Apr;20(4):501-9. doi: 10.1111/tmi.12452. Epub 2015 Jan 25.

4.

Genetic and antigenic structural characterization for resistance of echovirus 11 to pleconaril in an immunocompromised patient.

Benschop KS, Wildenbeest JG, Koen G, Minnaar RP, van Hemert FJ, Westerhuis BM, Pajkrt D, van den Broek PJ, Vossen AC, Wolthers KC.

J Gen Virol. 2015 Mar;96(Pt 3):571-9. doi: 10.1099/vir.0.069773-0. Epub 2014 Nov 13.

PMID:
25395595
5.

A tool to assess knowledge, attitude and behavior of Indonesian health care workers regarding infection control.

Duerink DO, Hadi U, Lestari ES, Roeshadi D, Wahyono H, Nagelkerke NJ, Van der Meulen RG, Van den Broek PJ.

Acta Med Indones. 2013 Jul;45(3):206-15.

6.

Appropriate use of indwelling urethra catheters in hospitalized patients: results of a multicentre prevalence study.

Jansen IA, Hopmans TE, Wille JC, van den Broek PJ, van der Kooi TI, van Benthem BH.

BMC Urol. 2012 Sep 6;12:25. doi: 10.1186/1471-2490-12-25.

7.

Urinary catheter policies for long-term bladder drainage.

Niël-Weise BS, van den Broek PJ, da Silva EM, Silva LA.

Cochrane Database Syst Rev. 2012 Aug 15;(8):CD004201. doi: 10.1002/14651858.CD004201.pub3. Review.

PMID:
22895939
8.

Differences in Acinetobacter baumannii strains and host innate immune response determine morbidity and mortality in experimental pneumonia.

de Breij A, Eveillard M, Dijkshoorn L, van den Broek PJ, Nibbering PH, Joly-Guillou ML.

PLoS One. 2012;7(2):e30673. doi: 10.1371/journal.pone.0030673. Epub 2012 Feb 8.

9.

Pleconaril revisited: clinical course of chronic enteroviral meningoencephalitis after treatment correlates with in vitro susceptibility.

Wildenbeest JG, van den Broek PJ, Benschop KS, Koen G, Wierenga PC, Vossen AC, Kuijpers TW, Wolthers KC.

Antivir Ther. 2012;17(3):459-66. doi: 10.3851/IMP1936. Epub 2011 Oct 24.

PMID:
22293148
10.

Three-dimensional human skin equivalent as a tool to study Acinetobacter baumannii colonization.

de Breij A, Haisma EM, Rietveld M, El Ghalbzouri A, van den Broek PJ, Dijkshoorn L, Nibbering PH.

Antimicrob Agents Chemother. 2012 May;56(5):2459-64. doi: 10.1128/AAC.05975-11. Epub 2012 Jan 30.

11.

Systematic review and meta-analysis of antibiotic prophylaxis to prevent infections from chest drains in blunt and penetrating thoracic injuries.

Bosman A, de Jong MB, Debeij J, van den Broek PJ, Schipper IB.

Br J Surg. 2012 Apr;99(4):506-13. doi: 10.1002/bjs.7744. Epub 2011 Dec 2. Review.

PMID:
22139619
12.

Emergence of MRSA of unknown origin in the Netherlands.

Lekkerkerk WS, van de Sande-Bruinsma N, van der Sande MA, Tjon-A-Tsien A, Groenheide A, Haenen A, Timen A, van den Broek PJ, van Wamel WJ, de Neeling AJ, Richardus JH, Verbrugh HA, Vos MC.

Clin Microbiol Infect. 2012 Jul;18(7):656-61. doi: 10.1111/j.1469-0691.2011.03662.x. Epub 2011 Oct 3.

13.

Eradication of carriage with methicillin-resistant Staphylococcus aureus: effectiveness of a national guideline.

Ammerlaan HS, Kluytmans JA, Berkhout H, Buiting A, de Brauwer EI, van den Broek PJ, van Gelderen P, Leenders SA, Ott A, Richter C, Spanjaard L, Spijkerman IJ, van Tiel FH, Voorn GP, Wulf MW, van Zeijl J, Troelstra A, Bonten MJ; MRSA Eradication Study Group.

J Antimicrob Chemother. 2011 Oct;66(10):2409-17. doi: 10.1093/jac/dkr243. Epub 2011 Jun 30.

PMID:
21719473
14.

Eradication of carriage with methicillin-resistant Staphylococcus aureus: determinants of treatment failure.

Ammerlaan HS, Kluytmans JA, Berkhout H, Buiting A, de Brauwer EI, van den Broek PJ, van Gelderen P, Leenders SA, Ott A, Richter C, Spanjaard L, Spijkerman IJ, van Tiel FH, Voorn GP, Wulf MW, van Zeijl J, Troelstra A, Bonten MJ; MRSA Eradication Study Group.

J Antimicrob Chemother. 2011 Oct;66(10):2418-24. doi: 10.1093/jac/dkr250. Epub 2011 Jun 30.

PMID:
21719471
15.

Urethral catheters: can we reduce use?

van den Broek PJ, Wille JC, van Benthem BH, Perenboom RJ, van den Akker-van Marle ME, Niël-Weise BS.

BMC Urol. 2011 May 23;11:10. doi: 10.1186/1471-2490-11-10.

16.

An evidence-based recommendation on bed head elevation for mechanically ventilated patients.

Niël-Weise BS, Gastmeier P, Kola A, Vonberg RP, Wille JC, van den Broek PJ; Bed Head Elevation Study Group.

Crit Care. 2011;15(2):R111. doi: 10.1186/cc10135. Epub 2011 Apr 11. Review.

17.

[Sterile gloves are necessary in minor surgery].

van den Broek PJ.

Ned Tijdschr Geneeskd. 2011;155(18):A3341. Dutch.

PMID:
21466736
18.

Bacterial aerosols during colonoscopy: something to be worried about?

van den Broek PJ.

Endoscopy. 2010 Sep;42(9):755-6. doi: 10.1055/s-0030-1255630. Epub 2010 Aug 30. No abstract available.

PMID:
20806159
19.

Determinants of carriage of resistant Staphylococcus aureus among S. aureus carriers in the Indonesian population inside and outside hospitals.

Lestari ES, Duerink DO, Hadi U, Severin JA, Nagelkerke NJ, Kuntaman K, Wahjono H, Gardjito W, Soejoenoes A, Van Den Broek PJ, Keuter M, Gyssens IC, Verbrugh HA; Group Antimicrobial Resistance in Indonesia Prevalence and Prevention.

Trop Med Int Health. 2010 Oct;15(10):1235-43. doi: 10.1111/j.1365-3156.2010.02600.x.

20.

How much time should long-term care and geriatric rehabilitation facilities (nursing homes) spend on infection control?

van den Broek PJ, Cools HJ, Wulf M, Das PH.

Am J Infect Control. 2010 Nov;38(9):723-5. doi: 10.1016/j.ajic.2010.03.008.

PMID:
20605266
21.

Should in-line filters be used in peripheral intravenous catheters to prevent infusion-related phlebitis? A systematic review of randomized controlled trials.

Niël-Weise BS, Stijnen T, van den Broek PJ.

Anesth Analg. 2010 Jun 1;110(6):1624-9. doi: 10.1213/ANE.0b013e3181da8342. Epub 2010 Apr 30. Review.

PMID:
20435946
22.

Endemic and epidemic acinetobacter species in a university hospital: an 8-year survey.

van den Broek PJ, van der Reijden TJ, van Strijen E, Helmig-Schurter AV, Bernards AT, Dijkshoorn L.

J Clin Microbiol. 2009 Nov;47(11):3593-9. doi: 10.1128/JCM.00967-09. Epub 2009 Sep 30.

23.

Morbidity and mortality associated with nosocomial transmission of oseltamivir-resistant influenza A(H1N1) virus.

Gooskens J, Jonges M, Claas EC, Meijer A, van den Broek PJ, Kroes AM.

JAMA. 2009 Mar 11;301(10):1042-6. doi: 10.1001/jama.2009.297. Epub 2009 Mar 2.

PMID:
19255111
24.

[Optimisation of the antibiotic policy in the Netherlands. XII. The SWAB guideline for antimicrobial eradication of MRSA in carriers].

Wertheim HF, Ammerlaan HS, Bonten MJ, van den Broek PJ, Troelstra A, Vandenbroucke-Grauls CM, Vos MC, Voss A, Nouwen JL, Kluytmans JA.

Ned Tijdschr Geneeskd. 2008 Dec 6;152(49):2667-71. Review. Dutch.

PMID:
19137966
25.

Transient and constitutive repression of cytoplasmic translation signaling in cells with mtDNA mutation.

Janssen GM, Schwertman P, Wanga TA, Tafrechi RS, van den Broek PJ, Raap AK.

Cell Mol Life Sci. 2009 Feb;66(4):721-30. doi: 10.1007/s00018-009-8687-4.

PMID:
19137259
26.

Trends in the incidence of surgical site infection in the Netherlands.

Manniën J, van den Hof S, Muilwijk J, van den Broek PJ, van Benthem B, Wille JC.

Infect Control Hosp Epidemiol. 2008 Dec;29(12):1132-8. doi: 10.1086/592094.

PMID:
18991504
27.

Can Escherichia coli be used as an indicator organism for transmission events in hospitals?

van den Broek PJ, Bernards AT, van der Reijden TJ, van Strijen B, Dijkshoorn L.

Eur J Clin Microbiol Infect Dis. 2009 Feb;28(2):169-73. doi: 10.1007/s10096-008-0597-0. Epub 2008 Aug 6.

PMID:
18682996
28.

Infection control measures to limit the spread of Clostridium difficile.

Vonberg RP, Kuijper EJ, Wilcox MH, Barbut F, Tüll P, Gastmeier P; European C difficile-Infection Control Group; European Centre for Disease Prevention and Control (ECDC), van den Broek PJ, Colville A, Coignard B, Daha T, Debast S, Duerden BI, van den Hof S, van der Kooi T, Maarleveld HJ, Nagy E, Notermans DW, O'Driscoll J, Patel B, Stone S, Wiuff C.

Clin Microbiol Infect. 2008 May;14 Suppl 5:2-20. doi: 10.1111/j.1469-0691.2008.01992.x. Review.

29.

Multifactorial origin of high incidence of Serratia marcescens in a cardio-thoracic ICU: analysis of risk factors and epidemiological characteristics.

de Boer MG, Brunsveld-Reinders AH, Salomons EM, Dijkshoorn L, Bernards AT, van den Berg PC, van den Broek PJ.

J Infect. 2008 Jun;56(6):446-53. doi: 10.1016/j.jinf.2008.04.001. Epub 2008 May 29.

PMID:
18511122
30.

Anti-infective-treated central venous catheters for total parenteral nutrition or chemotherapy: a systematic review.

Niël-Weise BS, Stijnen T, van den Broek PJ.

J Hosp Infect. 2008 Jun;69(2):114-23. doi: 10.1016/j.jhin.2008.02.020. Epub 2008 Apr 25. Review.

PMID:
18439717
31.

Limited value of chest radiography in predicting aetiology of lower respiratory tract infection in general practice.

Graffelman AW, Willemssen FE, Zonderland HM, Neven AK, Kroes AC, van den Broek PJ.

Br J Gen Pract. 2008 Feb;58(547):93-7. doi: 10.3399/bjgp08X264054.

32.

Anti-infective-treated central venous catheters: a systematic review of randomized controlled trials.

Niël-Weise BS, Stijnen T, van den Broek PJ.

Intensive Care Med. 2007 Dec;33(12):2058-68. Epub 2007 Oct 17. Review.

PMID:
17940746
33.

Determinants of carriage of resistant Escherichia coli in the Indonesian population inside and outside hospitals.

Duerink DO, Lestari ES, Hadi U, Nagelkerke NJ, Severin JA, Verbrugh HA, Keuter M, Gyssens IC, van den Broek PJ; Study Group Antimicrobial Resistance in Indonesia: Prevalence and Prevention (AMRIN).

J Antimicrob Chemother. 2007 Aug;60(2):377-84. Epub 2007 Jun 26.

PMID:
17595290
34.

Relationship between the AdeABC efflux system gene content, netilmicin susceptibility and multidrug resistance in a genotypically diverse collection of Acinetobacter baumannii strains.

Nemec A, Maixnerová M, van der Reijden TJ, van den Broek PJ, Dijkshoorn L.

J Antimicrob Chemother. 2007 Sep;60(3):483-9. Epub 2007 Jun 26.

PMID:
17595288
35.

Can history and exam alone reliably predict pneumonia?

Graffelman AW, le Cessie S, Knuistingh Neven A, Wilemssen FE, Zonderland HM, van den Broek PJ.

J Fam Pract. 2007 Jun;56(6):465-70.

PMID:
17543257
36.

Transmission of Pseudomonas aeruginosa in children with cystic fibrosis attending summer camps in The Netherlands.

Brimicombe RW, Dijkshoorn L, van der Reijden TJ, Kardoes I, Pitt TL, van den Broek PJ, Heijerman HG.

J Cyst Fibros. 2008 Jan;7(1):30-6. Epub 2007 May 25.

37.

Policies for endotracheal suctioning of patients receiving mechanical ventilation: a systematic review of randomized controlled trials.

Niël-Weise BS, Snoeren RL, van den Broek PJ.

Infect Control Hosp Epidemiol. 2007 May;28(5):531-6. Epub 2007 Mar 22. Review.

PMID:
17464911
38.
39.

Fourth human parechovirus serotype.

Benschop KS, Schinkel J, Luken ME, van den Broek PJ, Beersma MF, Menelik N, van Eijk HW, Zaaijer HL, VandenBroucke-Grauls CM, Beld MG, Wolthers KC.

Emerg Infect Dis. 2006 Oct;12(10):1572-5.

40.

How many infection control staff do we need in hospitals?

van den Broek PJ, Kluytmans JA, Ummels LC, Voss A, Vandenbroucke-Grauls CM.

J Hosp Infect. 2007 Feb;65(2):108-11. Epub 2006 Dec 14.

PMID:
17174007
41.

[Optimisation of the antibiotic policy in the Netherlands. X. The SWAB guideline for antimicrobial treatment of complicated urinary tract infections].

Geerlings SE, van den Broek PJ, van Haarst EP, Vleming LJ, van Haaren KM, Janknegt R, Platenkamp GJ, Prins JM.

Ned Tijdschr Geneeskd. 2006 Oct 28;150(43):2370-6. Review. Dutch.

PMID:
17100128
42.

Genotypic diversity and antibiotic susceptibility of Acinetobacter baumannii isolates in a Bulgarian hospital.

Dobrewski R, Savov E, Bernards AT, van den Barselaar M, Nordmann P, van den Broek PJ, Dijkshoorn L.

Clin Microbiol Infect. 2006 Nov;12(11):1135-7.

43.

Fragmented visuospatial processing in children with pervasive developmental disorder.

Schlooz WA, Hulstijn W, van den Broek PJ, van der Pijll AC, Gabreëls F, van der Gaag RJ, Rotteveel JJ.

J Autism Dev Disord. 2006 Nov;36(8):1025-37.

PMID:
16897391
44.

Epidemiology of multiple Acinetobacter outbreaks in The Netherlands during the period 1999-2001.

van den Broek PJ, Arends J, Bernards AT, De Brauwer E, Mascini EM, van der Reijden TJ, Spanjaard L, Thewessen EA, van der Zee A, van Zeijl JH, Dijkshoorn L.

Clin Microbiol Infect. 2006 Sep;12(9):837-43.

45.

Status of infection control policies and organisation in European hospitals, 2001: the ARPAC study.

Struelens MJ, Wagner D, Bruce J, MacKenzie FM, Cookson BD, Voss A, van den Broek PJ, Gould IM; ARPAC Steering Group.

Clin Microbiol Infect. 2006 Aug;12(8):729-37.

46.

Preventing nosocomial infections: improving compliance with standard precautions in an Indonesian teaching hospital.

Duerink DO, Farida H, Nagelkerke NJ, Wahyono H, Keuter M, Lestari ES, Hadi U, Van den Broek PJ; Antimicrobial Resistance in Indonesia: Prevalence and Prevention Study Group.

J Hosp Infect. 2006 Sep;64(1):36-43. Epub 2006 Jul 5.

PMID:
16822581
47.

Is there evidence for recommending needleless closed catheter access systems in guidelines? A systematic review of randomized controlled trials.

Niël-Weise BS, Daha TJ, van den Broek PJ.

J Hosp Infect. 2006 Apr;62(4):406-13. Epub 2006 Jan 31. Review.

PMID:
16448719
48.

Hair removal policies in clean surgery: systematic review of randomized, controlled trials.

Niël-Weise BS, Wille JC, van den Broek PJ.

Infect Control Hosp Epidemiol. 2005 Dec;26(12):923-8. Review.

PMID:
16417032
49.

[Meningococci infection by a bacteriophage with a virulence factor].

van den Broek PJ.

Ned Tijdschr Geneeskd. 2005 Nov 19;149(47):2600-2. Dutch.

PMID:
16355570
50.

Surveillance of healthcare-associated infections in Indonesian hospitals.

Duerink DO, Roeshadi D, Wahjono H, Lestari ES, Hadi U, Wille JC, De Jong RM, Nagelkerke NJ, Van den Broek PJ; Study Group 'antimicrobial Resistance In Indonesia Prevalence And Prevention' Amrin.

J Hosp Infect. 2006 Feb;62(2):219-29. Epub 2005 Nov 22.

PMID:
16307823

Supplemental Content

Loading ...
Support Center